Menu
GeneBe

TRAPPC12

trafficking protein particle complex subunit 12, the group of Trafficking protein particle complex subunits|Tetratricopeptide repeat domain containing

Basic information

Region (hg38): 2:3379674-3485094

Previous symbols: [ "TTC15" ]

Links

ENSG00000171853NCBI:51112OMIM:614139HGNC:24284Uniprot:Q8WVT3AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • early-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndrome (Limited), mode of inheritance: AR
  • early-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndrome (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Encephalopathy, progressive, early-onset, with brain atrophy and spasticity (PEBAS)ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingNeurologic28777934

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the TRAPPC12 gene.

  • not provided (99 variants)
  • Inborn genetic diseases (45 variants)
  • Early-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndrome (30 variants)
  • Progressive childhood encephalopathy (2 variants)
  • not specified (2 variants)
  • See cases (2 variants)
  • TRAPPC12-related condition (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the TRAPPC12 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
20
clinvar
15
clinvar
35
missense
1
clinvar
71
clinvar
7
clinvar
6
clinvar
85
nonsense
2
clinvar
1
clinvar
1
clinvar
4
start loss
0
frameshift
2
clinvar
3
clinvar
5
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
4
clinvar
4
splice region
1
1
3
1
1
7
non coding
1
clinvar
1
clinvar
9
clinvar
7
clinvar
18
Total 5 9 74 36 28

Highest pathogenic variant AF is 0.0000131

Variants in TRAPPC12

This is a list of pathogenic ClinVar variants found in the TRAPPC12 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
2-3387642-G-A Inborn genetic diseases Uncertain significance (Dec 06, 2022)2401189
2-3387648-G-C Inborn genetic diseases Conflicting classifications of pathogenicity (Oct 16, 2023)2221667
2-3387652-C-T Inborn genetic diseases Uncertain significance (Nov 12, 2021)2229824
2-3387661-C-T Uncertain significance (Jun 29, 2023)2902792
2-3387664-A-T Inborn genetic diseases Uncertain significance (May 01, 2023)2197518
2-3387673-AC-A Early-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndrome Likely pathogenic (-)2584443
2-3387678-C-T Inborn genetic diseases Uncertain significance (Sep 04, 2023)2236089
2-3387687-G-A TRAPPC12-related disorder Benign/Likely benign (Jan 22, 2024)1614588
2-3387692-T-A TRAPPC12-related disorder Likely benign (Aug 16, 2019)3053837
2-3387696-GA-TT Uncertain significance (Nov 11, 2022)2901969
2-3387697-A-T Inborn genetic diseases Uncertain significance (Jan 23, 2024)3181977
2-3387711-C-G Uncertain significance (May 22, 2023)2064918
2-3387731-C-T TRAPPC12-related disorder Likely benign (Aug 20, 2019)3052743
2-3387767-CG-C Early-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndrome Likely pathogenic (Jun 20, 2019)438738
2-3387768-G-A TRAPPC12-related disorder Benign/Likely benign (Jan 25, 2024)1530005
2-3387779-G-A Likely benign (Apr 11, 2023)2892735
2-3387798-G-A Benign (Jan 17, 2024)1671030
2-3387799-C-T Inborn genetic diseases Likely benign (Feb 23, 2023)2488328
2-3387814-AAC-A Early-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndrome Likely pathogenic (-)2585068
2-3387821-G-T Inborn genetic diseases Uncertain significance (Feb 10, 2022)2221208
2-3387823-T-C Inborn genetic diseases Uncertain significance (Dec 07, 2021)2265728
2-3387866-CGCGGGCGACCTGGGCCGAGT-C Early-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndrome Likely pathogenic (Mar 29, 2024)3065808
2-3387867-G-A Inborn genetic diseases Uncertain significance (Oct 20, 2021)2356601
2-3387868-C-CGGGCGACCT Early-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndrome Uncertain significance (Sep 14, 2021)2437251
2-3387872-C-T Likely benign (Jan 12, 2024)3013852

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
TRAPPC12protein_codingprotein_codingENST00000324266 11105420
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
5.36e-160.04921256850631257480.000251
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.1604574670.9790.00003184744
Missense in Polyphen136143.540.947481459
Synonymous0.3712132200.9680.00001841466
Loss of Function0.7132630.20.8600.00000152331

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0007700.000765
Ashkenazi Jewish0.0005120.000496
East Asian0.0001670.000163
Finnish0.000.00
European (Non-Finnish)0.0002620.000237
Middle Eastern0.0001670.000163
South Asian0.0002510.000229
Other0.0001630.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Component of the TRAPP complex, which is involved in endoplasmic reticulum to Golgi apparatus trafficking at a very early stage (PubMed:21525244, PubMed:28777934). Also plays a role in chromosome congression, kinetochore assembly and stability and controls the recruitment of CENPE to the kinetochores (PubMed:25918224). {ECO:0000269|PubMed:21525244, ECO:0000269|PubMed:25918224, ECO:0000269|PubMed:28777934}.;
Disease
DISEASE: Encephalopathy, progressive, early-onset, with brain atrophy and spasticity (PEBAS) [MIM:617669]: An autosomal recessive, progressive encephalopathy characterized by central nervous system atrophy and dysfunction, spasticity, microcephaly, global developmental delay, and hearing loss. {ECO:0000269|PubMed:28777934}. Note=The disease is caused by mutations affecting the gene represented in this entry. Cells display a fragmented Golgi apparatus (PubMed:28777934). {ECO:0000269|PubMed:28777934}.;
Pathway
Vesicle-mediated transport;Membrane Trafficking;Rab regulation of trafficking;RAB GEFs exchange GTP for GDP on RABs (Consensus)

Recessive Scores

pRec
0.102

Intolerance Scores

loftool
rvis_EVS
-0.39
rvis_percentile_EVS
27.05

Haploinsufficiency Scores

pHI
0.0838
hipred
N
hipred_score
0.251
ghis
0.529

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.114

Gene Damage Prediction

AllRecessiveDominant
MendelianHighHighHigh
Primary ImmunodeficiencyHighHighHigh
CancerHighHighHigh

Mouse Genome Informatics

Gene name
Trappc12
Phenotype

Gene ontology

Biological process
proteolysis;endoplasmic reticulum to Golgi vesicle-mediated transport;Golgi organization;protein complex oligomerization;metaphase plate congression;regulation of kinetochore assembly;positive regulation of protein localization to kinetochore
Cellular component
kinetochore;nucleus;endoplasmic reticulum-Golgi intermediate compartment;cytosol;TRAPP complex;perinuclear region of cytoplasm
Molecular function
endopeptidase activity;protein binding;Rab guanyl-nucleotide exchange factor activity